Adding monounsaturated fatty acids to a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia

Jenkins, David J. A.; Chiavaroli, Laura; Wong, Julia M. W.; Kendall, Cyril; Lewis, Gary F.; Vidgen, Edward; Connelly, Philip W.; Leiter, Lawrence A.; Josse, Robert G.; Lamarche, Benot
December 2010
CMAJ: Canadian Medical Association Journal;12/14/2010, Vol. 182 Issue 18, p1961
Academic Journal
Background: Higher intake of monounsaturated fat may raise high-density lipoprotein (HDL) cholesterol without raising low-density lipoprotein (LDL) cholesterol. We tested whether increasing the monounsaturated fat content of a diet proven effective for lowering LDL cholesterol (dietary portfolio) also modified other risk factors for cardiovascular disease, specifically by increasing HDL cholesterol, lowering serum triglyceride and further reducing the ratio of total to HDL cholesterol. Methods: Twenty-four patients with hyperlipidemia consumed a therapeutic diet very low in saturated fat for one month and were then randomly assigned to a dietary portfolio low or high in monounsaturated fatty acid for another month. We supplied participants' food for the two-month period. Calorie intake was based on Harris-Benedict estimates for energy requirements. Results: For patients who consumed the dietary portfolio high in monounsaturated fat, HDL cholesterol rose, whereas for those consuming the dietary portfolio low in monounsaturated fat, HDL cholesterol did not change. The 12.5% treatment difference was significant (0.12 mmol/L, 95% confidence interval [CI] 0.05 to 0.21, p = 0.003). The ratio of total to HDL cholesterol was reduced by 6.5% with the diet high in monounsaturated fat relative to the diet low in monounsaturated fat (-0.28, 95% CI -0.59 to -0.04, p = 0.025). Patients consuming the diet high in monounsaturated fat also had significantly higher concentrations of apolipoprotein AI, and their C-reactive protein was significantly lower. No treatment differences were seen for triglycerides, other lipids or body weight, and mean weight loss was similar for the diets high in monounsaturated fat (-0.8 kg) and low in monounsaturated fat (-1.2 kg). Interpretation: Monounsaturated fat increased the effectiveness of a cholesterol-lowering dietary portfolio, despite statin-like reductions in LDL cholesterol. The potential benefits for cardiovascular risk were achieved through increases in HDL cholesterol, further reductions in the ratio of total to HDL cholesterol and reductions in C-reactive protein.


Related Articles

  • Emerging therapeutic strategies to enhance HDL function.  // Lipids in Health & Disease;2011, Vol. 10 Issue 1, p175 

    The article cites a research study that examines the role of high-density lipoproteins (HDL) in the treatment of cardiovascular disease (CVD). Reverse cholesterol transport (RCT) is thought to be the most relevant cardioprotective mechanism mediated by HDL. The development of promising agents...

  • Nonalcoholic Fatty Liver Disease Is Associated with a Qualitative Change in the HDL Cholesterol Sub-Fractions and Their Fatty Acid Patterns. Kantartzis, Konstantinos; Rittig, Kilian; Cegan, Alexander; Thamer, Claus; Machann, Jürgen; Balletshofer, Bernd; Fritsche, Andreas; Schleicher, Erwin; Häring, Hansulrich; Stefan, Norbert // Diabetes;Jun2007 Supplement 1, Vol. 56, pA680 

    Nonalcoholic fatty liver disease (NAFLD) is strongly associated with atherosclerosis. Mechanisms explaining this relationship include a quantitative change in serum levels of triglycerides (TG), high-density lipoprotein cholesterol (HDL-c) and an increase in small dense LDL particles. So far it...

  • The effect of dietary phytosphingosine on cholesterol levels and insulin sensitivity in subjects with the metabolic syndrome. Snel, M.; Sleddering, M. A.; Pijl, H.; Nieuwenhuizen, W. F.; Frölich, M.; Havekes, L. M.; Romijn, J. A.; Jazet, I. M. // European Journal of Clinical Nutrition;Apr2010, Vol. 64 Issue 4, p419 

    Background:Sphingolipids, like phytosphingosine (PS) are part of cellular membranes of yeasts, vegetables and fruits. Addition of PS to the diet decreases serum cholesterol and free fatty acid (FFA) levels in rodents and improves insulin sensitivity.Objective:To study the effect of dietary...

  • Large-Scale Candidate Gene Analysis of HDL Particle Features. Kaess, Bernhard M.; Tomaszewski, Maciej; Braund, Peter S.; Stark, Klaus; Rafelt, Suzanne; Fischer, Marcus; Hardwick, Robert; Nelson, Christopher P.; Debiec, Radoslaw; Huber, Fritz; Kremer, Werner; Kalbitzer, Hans Robert; Rose, Lynda M.; Chasman, Daniel I.; Hopewell, Jemma; Clarke, Robert; Burton, Paul R.; Tobin, Martin D.; Hengstenberg, Christian; Samani, Nilesh J. // PLoS ONE;2011, Vol. 6 Issue 1, p1 

    Background: HDL cholesterol (HDL-C) is an established marker of cardiovascular risk with significant genetic determination. However, HDL particles are not homogenous, and refined HDL phenotyping may improve insight into regulation of HDL metabolism. We therefore assessed HDL particles by NMR...

  • FAT or FICTION? White, Jon // New Scientist;8/2/2014, Vol. 223 Issue 2980, p32 

    The article focuses on research showing the health effects of saturated fat in 2014. Topics include the dangers of cardiovascular disease on humans, if a diet high in saturated fat increases the risk of heart attack and stroke, and the decline in heart disease-related deaths in Western nations...

  • RELATION BETWEEN ADIPONECTIN AND THE TOTAL CHOLESTEROL/HDL-CHOLESTEROL RATIO IN DIABETIC PATIENTS. Gligor, Ramona; Crîsnic, I.; Puşchiţa, Maria; Zdremţan, Dana // Annals of the Romanian Society for Cell Biology;2011, Vol. 16 Issue 1, p144 

    There were studied a number of 60 diabetes patients. There were determined the following: fasting glycemia, total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, fibrinogen, C reactive protein (CRP), glycosilated hemoglobin and adiponectin. From the patients, 19 were males, 41 were...

  • Cholesteryl Ester Transfer Protein: A Potential Target for the Treatment of Coronary Artery Disease. Patel, Harsha; Jigna Shah; Patel, Sunita; Anand, I. S. // Indian Journal of Pharmaceutical Sciences;2007, Vol. 69 Issue 6, p735 

    High-density lipoprotein cholesterol levels have a strong inverse association with a risk of cardiovascular disease. Even patients on statin therapy whose low-density lipoprotein cholesterol levels are well controlled may be at high risk for developing cardiovascular disease if their...

  • Ask Dr. Oz. Oz, Mehmet // Esquire;Mar2004, Vol. 141 Issue 3, p94 

    Discusses the physiological benefits from cholesterol drugs. Purpose of high-density lipoproteins (HDL); Details of the Italian research on people with low HDL; Health tips for patients with heart disease.

  • Is raising HDL a futile strategy for atheroprotection? Joy, Tisha; Hegele, Robert A. // Nature Reviews Drug Discovery;Feb2008, Vol. 7 Issue 2, p143 

    The dramatic failure of clinical trials evaluating the cholesterol ester transfer protein inhibitor torcetrapib has led to considerable doubt about the value of raising high-density lipoprotein cholesterol (HDL-C) as a treatment for cardiovascular disease. These results have underscored the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics